Alpharetta, GA, United States of America

R Martin Emanuele

This inventor holds 29 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Cytrx Corporation, Artelo Biosciences, Inc., Emory University. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Martin Emanuele. Retrieved from https://idiyas.com/inventor/r-martin-emanuele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 6)

% Patents Active = 89.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 359(Granted Patents)

Location History:

Hillbrook, GA (US) (1999)
Alpharetta, GA (US) (1995 - 2007)
San Diego, CA (US) (2016 - 2022)

Company Filing History:

Artelo Biosciences, Inc.

Liferaft Biosciences, Inc.

patents

5. 2 out of 40

Rush-Presbyterian-St. Luke's Medical Center

patents

6. 1 out of 3

Aires Pharmaceuticals, Inc.

patents

7. 1 out of 4

Mast Therapeutics, Inc.

patents

8. 1 out of 1

Rush Prebyterian-St. Luke Medical Center

patent

9. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2026

Loading Chart...

Areas of Expertise:

Cannabidiol

Poloxamer

Therapeutic Delivery

Vaccine Adjuvant

Biological Activity

Antiinfective Compounds

Multidrug Resistance

Gel Composition

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655083 - Solid forms of cannabidiol and uses thereof (2026-06-16),

2. 11364202 - Solid forms of cannabidiol and uses thereof (2022-06-21),

3. 11155679 - Poloxamer composition free of long circulating material and methods for production and uses thereof (2021-10-26),

4. 10604467 - Solid forms of cannabidiol and uses thereof (2020-03-31),

5. 10501577 - Poloxamer composition free of long circulating material and methods for production and uses thereof (2019-12-10),

6. 9757411 - Poloxamer therapy for heart failure (2017-09-12),

7. 9403941 - Poloxamer composition free of long circulating material and methods for production and uses thereof (2016-08-02),

8. 7202225 - Therapeutic delivery compositions and methods of use thereof (2007-04-10),

9. 7045576 - Adjuvants and copolymer compositions (2006-05-16),

10. 6933286 - Therapeutic delivery compositions and methods of use thereof (2005-08-23),

11. RE38558 - Polyoxypropylene/polyoxyethylene copolymers with improved biological activity (2004-07-20),

12. 6747064 - Polyoxypropylene/polyoxyethylene copolymers with improved biological activity (2004-06-08),

13. 6416947 - Vaccine adjuvant and vaccine method (2002-07-09),

14. 6359014 - Polyoxypropylene/polyoxyethylene copolymers with improved biological activity (2002-03-19),

15. RE37285 - Polyoxypropylene/polyoxyethylene copolmers with improved biological activity (2001-07-17),

Title: Innovator Spotlight: R Martin Emanuele

Introduction:

R Martin Emanuele, a prolific inventor based in Alpharetta, GA, has made significant contributions to the field of pharmaceuticals with his numerous patents and innovative creations. With a total of 28 patents to his name, Emanuele's work has been instrumental in advancing the medical and healthcare industries.

Latest Patents:

One of Emanuele's recent patents includes the development of solid forms of cannabidiol and their various uses. These cocrystals of cannabidiol and specific coformers have opened up new possibilities for the utilization of this compound in different applications. Additionally, his work on Poloxamer compositions free of long circulating material has paved the way for improved medical treatments and formulations.

Career Highlights:

Throughout his career, Emanuele has been associated with renowned companies such as CytRx Corporation and Rush-Presbyterian-St. Luke's Medical Center. His expertise and dedication to innovation have been evident in the groundbreaking projects he has been involved in, pushing the boundaries of pharmaceutical research and development.

Collaborations:

Emanuele has had the privilege of collaborating with esteemed professionals in the field, including Mannarsamy Balasubramanian and Robert L Hunter. These collaborations have not only enriched his own work but have also led to the creation of impactful patents and inventions that have influenced the industry at large.

Conclusion:

In conclusion, R Martin Emanuele stands as a trailblazing inventor whose commitment to innovation has left a lasting imprint on the pharmaceutical sector. His ingenuity, coupled with his collaborative spirit, continues to drive forward new ideas and solutions that have the potential to shape the future of healthcare and medicine.

Profile summary based on public USPTO records.